Advertisement

What Have We Learned in the Last 20 Years About CRT Non-Responders?

  • Peregrine G. Green
    Affiliations
    Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Parks Road, Oxford, OX1 3PT, UK

    Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Level 0 John Radcliffe Hospital, Oxford, OX3 9DU, UK

    Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK
    Search for articles by this author
  • Neil Herring
    Affiliations
    Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Parks Road, Oxford, OX1 3PT, UK

    Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK
    Search for articles by this author
  • Timothy R. Betts
    Correspondence
    Corresponding author. Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK.
    Affiliations
    Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK

    Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Glikson M.
        • Nielsen J.C.
        • Kronborg M.B.
        • et al.
        2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) with the special contribution of the European Heart Rhythm Association (EHRA).
        Eur Heart J. 2021; https://doi.org/10.1093/eurheartj/ehab364
        • Mcdonagh T.A.
        • Metra M
        • Adamo M
        • et al.
        2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2021; https://doi.org/10.1093/eurheartj/ehab368
        • Sohaib S.M.
        • Chen Z.
        • Whinnett Z.I.
        • et al.
        Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy.
        Eur J Heart Fail. 2013; 15 (ISSN 1879-0844 (Electronic) 1388-9842 (Linking). Disponível em: Available at:): 1419-1428
      1. Daubert, C., Behar N., Martins R.P. et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. European Heart Journal, Volume 38, Issue 19, 2017, Pages 1463–1472.

        • Rickard J.
        • Cheng A
        • Spragg D
        • et al.
        Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of “nonresponders”.
        Heart Rhythm. 2014; (1556-3871 (Electronic))
        • Ypenburg C.
        • van Bommel R.J.
        • Borleffs J.W.
        • et al.
        Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
        J Am Coll Cadiol. 2009; (1558-3597 (Electronic))
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • et al.
        Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350 (ISSN 1533-4406 (Electronic) 0028-4793 (Linking). Disponível em: Available at:) (>Disponível em): 2140-2150
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361 (ISSN 1533-4406 (Electronic) 0028-4793 (Linking). Disponível em: Available at:): 1329-1338
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • et al.
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352 (ISSN 1533-4406 (Electronic) 0028-4793 (Linking). Disponível em: Available at:): 1539-1549
        • Cazeau S.
        • Leclercq C.
        • Lavergne T.
        • et al.
        Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
        N Engl J Med. 2001; 344 (n. 0028-4793): 873-880
        • Tang A.S.
        • Wells G.A.
        • Talajic M
        • et al.
        Cardiac-resynchronization therapy for mild-to-moderate heart failure.
        N Engl J Med. 2010; 363 (ISSN 1533-4406 (Electronic)0028-4793 (Linking). Disponível em: Available at:): 2385-2395
        • Abraham W.T.
        • Fisher W.G.
        • Smith A.L.
        • et al.
        Cardiac resynchronization in chronic heart failure.
        N Engl J Med. 2002; 346 (1533-4406): 1845-1853
        • Fornwalt B.K.
        • Sprague W.W.
        • BeDell P.
        • et al.
        Agreement is poor among current criteria used to define response to cardiac resynchronization therapy.
        Circulation. 2010; 121 (1524-4539 (Electronic)): 1985-1991
        • Sieniewicz B.J.
        • Gould J.
        • Porter B.
        • et al.
        Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.
        Heart Fail Rev. 2019; 24 (1573-7322 (Electronic)): 41-54
        • Daubert JC FAU - SAXON L.
        • au fnm
        • au fnm
        • et al.
        Heart Rhythm. 2012; 9: 1524-1576
        • Varma N.
        • Boehmer J.
        • Bhargava K.
        • et al.
        Evaluation, management, and outcomes of patients poorly responsive to cardiac resynchronization device therapy.
        J Am Coll Cardiol. 2019; 74 (ISSN 0735-1097. Disponível em: Available at:): 2588-2603
        • Steffel J.
        • Milosevic G
        • Hurlimann A
        • et al.
        Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: ‘real world’ experience from a single tertiary care centre. n. 1468-201X (Electronic).
        Heart. 2011; 97: 1668-1674
        • Steffel J.
        • Ruschitzka F.
        Superresponse to cardiac resynchronization therapy.
        Circulation. 2014; 130 (1524-4539 (Electronic)): 87-90
        • Oka T.
        • Inoue K
        • Tanaka K
        • et al.
        Duration of reverse remodeling response to cardiac resynchronization therapy: rates, predictors, and clinical outcomes. n. 1874-1754 (Electronic).
        Int J Cardiol. 2017; 243: 340-346
        • Gold M.R.
        • Rickard J.
        • Daubert J.C.
        • et al.
        Redefining the Classifications of response to cardiac resynchronization therapy: results from the REVERSE study.
        JACC Clin Electrophysiol. 2021; 7 (2405-5018 (Electronic)): 871-880
        • Coppola G.
        • Ciaramitaro G.
        • Stabile G.
        • et al.
        Magnitude of QRS duration reduction after biventricular pacing identifies responders to cardiac resynchronization therapy.
        Int J Cardiol. 2016; 221 (1874-1754 (Electronic)): 450-455
        • Bazoukis G.
        • Naka K.K.
        • Alsheikh-Ali A
        • et al.
        Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies.
        Heart Fail Rev. 2020; 25: 745-756
        • Rickard J.
        • Popovic Z.
        • Verhaert D.
        • et al.
        The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
        Pacing Clin Electrophysiol. 2011; 34 (n. 1540-8159 (Electronic)): 604-611
        • Coverstone E.
        • Sheehy J.
        • Kleiger R.E.
        • et al.
        The postimplantation electrocardiogram predicts clinical response to cardiac resynchronization therapy.
        Pacing Clin Electrophysiol. 2015; 38 (1540-8159 (Electronic)): 572-580
        • Bode W.D.
        • Bode M.F.
        • Gettes L.
        • et al.
        Prominent R wave in ECG lead V1 predicts improvement of left ventricular ejection fraction after cardiac resynchronization therapy in patients with or without left bundle branch block.
        Heart Rhythm. 2015 Oct; 12: 2141-2147
        • Zusterzeel R.
        • Selzman K.A.
        • Sanders W.E.
        • et al.
        Toward Sex-specific guidelines for cardiac resynchronization therapy?.
        J Cardiovasc Transl Res. 2016; 9 (n. 1937-5395 (Electronic)): 12-22
        • Zabarovskaja S.
        • Gadler F.
        • Braunschweig F.
        • et al.
        Women have better long-term prognosis than men after cardiac resynchronization therapy.
        Europace. 2012; 14 (1532-2092 (Electronic)): 1148-1155
        • Zusterzeel R.
        • Curtis J.P.
        • Caños D.A.
        • et al.
        Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.
        J Am Coll Cardiol. 2014; 64 (ISSN 0735-1097. Disponível em: Available at:): 887-894
        • Zusterzeel R.
        • Spatz E.S.
        • Curtis J.P.
        • et al.
        Cardiac resynchronization therapy in women versus men.
        Circ Cardiovasc Qual Outcomes. 2015; 8: S4-S11https://doi.org/10.1161/CIRCOUTCOMES.114.001548 >. Acesso em: 2021/09/02
        • Zusterzeel R.
        • Selzman K.A.
        • Sanders W.E.
        • et al.
        Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
        JAMA Intern Med. 2014; 174 (ISSN 2168-6106. Disponível em:): 1340-1348https://doi.org/10.1001/jamainternmed.2014.2717>. Acesso em: 9/2/2021
        • Verbrugge F.H.
        • Dupont M.
        • Rivero-Ayerza M.
        • et al.
        Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.
        J Card Fail. 2012; 18 (1532-8414 (Electronic)): 845-853
        • Bazoukis G.
        • Letsas K.P.
        • Korantzopoulos P.
        • et al.
        Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: a systematic review and meta-analysis.
        J Arrhythm. 2017; 33 (ISSN 1880-4276. Disponível em:): 417-423https://doi.org/10.1016/j.joa.2017.04.005>. Acesso em: 2021/09/28
        • Ghali J.K.
        • Boehmer J.
        • Feldman A.M.
        • et al.
        Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
        J Card Fail. 2007; 13 (ISSN 1532-8414 (Electronic) 1071-9164 (Linking). Disponível em: Available at:): 769-773
        • George J.
        • Barsheshet A.
        • Moss A.J.
        • et al.
        Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy.
        Ann Noninvasive Electrocardiol. 2012; 17 (. ISSN 1542-474X (Electronic) 1082-720X (Linking). Disponível em: Available at:): 14-21
        • Sun H.
        • Guan Y.
        • Wang L.
        • et al.
        2015 Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis.
        BMC Cardiovasc Disord. 2015; 15 (ISSN 1471-2261 (Electronic) 1471-2261 (Linking). Disponível em: Available at:): 25
        • Echouffo-tcheugui J.B.
        • Masoudi F.A.
        • Bao H.
        • et al.
        Diabetes mellitus and outcomes of cardiac resynchronization with implantable Cardioverter-defibrillator therapy in Older patients with heart failure.
        Circ Arrhythm Electrophysiol. 2016; 9 (ISSN 1941-3084 (Electronic) 1941-3084 (Linking). Disponível em: Available at:): 8
        • SHAH R.V.
        • Altman R.K.
        • Park M.Y.
        • et al.
        Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure.
        Am J Cardiol. 2012; 110 (ISSN 1879-1913 (Electronic) 0002-9149 (Linking). Disponível em: Available at:): 683-688
        • Mangiavacchi M.
        • Gasparini M.
        • Genovese S.
        • et al.
        Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.
        Pacing Clin Electrophysiol. 2008; 31 (ISSN 1540-8159 (Electronic) 0147-8389 (Linking). Disponível em: Available at:): 1425-1432
        • Hoke U.
        • Thijssen J.
        • van Bommel R.J.
        • et al.
        Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy.
        Diabetes Care. 2013; 36 (ISSN 1935-5548 (Electronic) 0149-5992 (Linking). Disponível em: Available at:): 985-991
        • Martens P.
        • Verbrugge F.
        • Nijst P.
        • et al.
        Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy.
        Am J Cardiol. 2017; 119 (ISSN 0002-9149. Disponível em:): 65-70https://doi.org/10.1016/j.amjcard.2016.09.017>. Acesso em: 2021/09/28
        • Dauw J.
        • Martens P.
        • Mullens W.
        CRT optimization: what is new? What is necessary?.
        Curr Treat Options Cardiovasc Med. 2019; 21 (Available at: ISSN 1534-3189. Disponível em.): 45https://doi.org/10.1007/s11936-019-0751-2
        • Martens P.
        • Dupont M.
        • Dauw J.
        • et al.
        The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial.
        European Heart Journal. 2021; 42: 4905-4914
      2. Cleland, J. Freemantel N., Ghio S., et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a Report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008 Aug 5;52(6):438-45

        • Goldenberg I.
        • Moss A.J.
        • Jackson Hall W.
        • et al.
        Predictors of response to cardiac resynchronization therapy in the Multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
        Circulation. 2011; 124 (1524-4539 (Electronic)): 1527-1536
        • Tian Y.
        • Zhang P.
        • Li X.
        • et al.
        True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy.
        Europace. 2013; 15 (1532-2092 (Electronic)): 1499-1506
        • Cunnington C.
        • Kwok C.S.
        • Satchithananda D.K.
        • et al.
        Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials.
        PLoS One. 2019; 14 (1468-201X (Electronic)): e0206611
        • Sipahi I.
        • Chou J.C.
        • Hyden M
        • et al.
        Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
        Am Heart J. 2012; 163 (1097-6744 (Electronic)): 260-267.e3
        • Birnie D.H.
        • Ha A
        • Higginson L.
        • et al.
        Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: results from the resynchronization-Defibrillation for ambulatory heart failure trial (RAFT).
        Circ Heart Fail. 2013; 6 (1941-3297 (Electronic)): 1190-1198
        • Sipahi I.
        • Carrigan T.P.
        • Rowland D.Y.
        • et al.
        Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
        Arch Intern Med. 2011; 171 (1538-3679 (Electronic)): 1454-1462
        • Gasparini M.
        • Leclercq C.
        • Yu C.M.
        • et al.
        Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
        Am Heart J. 2014; 167 (Disponível em: Available at:): 203-e1
        • Sundaram V.
        • Sahadevan J.
        • Waldo A.L.
        • et al.
        Implantable Cardioverter-Defibrillators with versus without resynchronization therapy in patients with a QRS duration >180 ms.
        J Am Coll Cardiol. 2017; 69 (Disponível em: Available at:): 2026-2036https://doi.org/10.1016/j.jacc.2017.02.042 >. Acesso em: 2021/10/07
      3. Mullens, W., Grimm R.A., Verga T. et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009 Mar 3;53(9):765-73

        • Mullens W.
        • Kepa J.
        • De Vusser P.
        • et al.
        Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy.
        Am J Cardiol. 2011; 108 (1879-1913 (Electronic)): 409-415
        • Alvarez-alvarez B.
        • García-Seara J.
        • Martínez-Sande J.L.
        • et al.
        Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy.
        J Arrhythm. 2018; 34 (n. 1880-4276 (Print)): 548-555
        • Chun K.H.
        • Oh J.
        • Yu H.T.
        • et al.
        The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non-responders: a retrospective analysis.
        ESC Heart Fail. 2020; 7 (2055-5822 (Electronic)): 4404-4407
        • Schmidt S.
        • Hurlimann D.
        • Starck C.T.
        • et al.
        Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
        Eur Heart J. 2014; 35 (1522-9645 (Electronic)): 1051-1060
        • Witt C.T.
        • Kronborg M.B.
        • Nohr E.A.
        • et al.
        Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival.
        Eur Heart J Cardiovasc Pharmacother. 2015; 1 (2055-6845 (Electronic)): 182-188
        • Kutyifa V.
        • Kosztin A.
        • Klein H.U.
        • et al.
        Left ventricular lead location and long-term outcomes in cardiac resynchronization therapy patients.
        JACC Clin Electrophysiol. 2018; 4 (ISSN 2405-500X. Disponível em: Available at:): 1410-1420
        • Thébault C.
        • Donal E.
        • Meunier C.
        • et al.
        Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
        Eur Heart J. 2012; 33 (ISSN 0195-668X. Disponível em:): 2662-2671https://doi.org/10.1093/eurheartj/ehr505>. Acesso em: 9/28/2021
        • Behon A.
        • Schwertner W.R.
        • Merkel E.D.
        • et al.
        Lateral left ventricular lead position is superior to posterior position in long-term outcome of patients who underwent cardiac resynchronization therapy.
        ESC Heart Fail. 2020; 7 (ISSN 2055-5822. Disponível em:): 3374-3382https://doi.org/10.1002/ehf2.13066 >. Acesso em: 2021/09/28
        • Gold M.R.
        • Birgersdotter-Green U.
        • Singh J.P.
        • et al.
        The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.
        Eur Heart J. 2011; 32 (1522-9645 (Electronic)): 2516-2524
        • Roubicek T.
        • Wichterle D.
        • Kucera P.
        • et al.
        Left ventricular lead electrical delay is a predictor of mortality in patients with cardiac resynchronization therapy.
        Circ Arrhythm Electrophysiol. 2015; 8 (1941-3084 (Electronic)): 1113-1121
        • Gold M.R.
        • Singh J.P.
        • Ellenbogen K.A.
        • et al.
        Interventricular electrical delay is predictive of response to cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2016; 2 (2405-5018 (Electronic)): 438-447
        • Gold M.R.
        • Yu Y.
        • Wold N.
        • et al.
        The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.
        Heart Rhythm. 2017; 14 (1556-3871 (Electronic)): 1748-1755
        • Khan F.Z.
        • Virdee M.S.
        • Palmer C.R.
        • et al.
        Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
        J Am Coll Cardiol. 2012; 59 (1558-3597 (Electronic)): 1509-1518
        • Saba S.
        • Marek J.
        • Schwartzman D.
        • et al.
        Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.
        Circ Heart Fail. 2013; 6 (1941-3297 (Electronic)): 427-434
        • Chen Z.
        • Sohal M.
        • Sammut E.
        • et al.
        Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy.
        J Cardiovasc Electrophysiol. 2016 Feb; 27: 203-209
        • Daoulah A.
        • Alsheikh-Ali A.A.
        • Al-Faifi S.M.
        • et al.
        Cardiac resynchronization therapy in patients with postero-lateral scar by cardiac magnetic resonance: a systematic review and meta-analysis.
        J Electrocardiol. 2015; 48 (1532-8430 (Electronic)): 783-790
        • Sommer A.
        • Kronborg M.B.
        • Nørgaard B.L.
        • et al.
        Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. n. 1879-0844 (Electronic).
        Eur J Heart Fail. 2016; 18: 1365-1374
        • Beshai J.F.
        • Grimm R.A.
        • Nagueh S.F.
        • et al.
        Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
        N Engl J Med. 2007; 357 (ISSN 0028-4793. Disponível em:): 2461-2471https://doi.org/10.1056/NEJMoa0706695 >. Acesso em: 2021/09/02
        • Donahue T.
        • Niazi I.
        • Leon A.
        • et al.
        Acute and chronic response to CRT in narrow QRS patients.
        J Cardiovasc Transl Res. 2012; 5 (1937-5395 (Electronic)): 232-241
        • Ruschitzka F.
        • Abraham W.T.
        • Singh J.P.
        • et al.
        Cardiac-resynchronization therapy in heart failure with a narrow QRS Complex.
        N Engl J Med. 2013; 369 (ISSN 0028-4793. Disponível em:): 1395-1405https://doi.org/10.1056/NEJMoa1306687 >. Acesso em: 2021/09/02
        • Chung E.S.
        • Leon A.R.
        • Tavazzi L.
        • et al.
        Results of the predictors of response to CRT (PROSPECT) trial.
        Circulation. 2008; 117 (1524-4539 (Electronic)): 2608-2616
        • Yu C.M.
        • Sanderson J.E.
        • Gorcsan III., J.
        Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.
        Eur Heart J. 2010; 31 (ISSN 0195-668X. Disponível em:): 2326-2337https://doi.org/10.1093/eurheartj/ehq263>. Acesso em: 10/7/2021
        • Vijayaraman P.
        • Subzposh F.A.
        His-bundle pacing and LV endocardial pacing as alternatives to Traditional cardiac resynchronization therapy.
        Curr Cardiol Rep. 2018; 20 (1534-3170 (Electronic)): 109
        • Behar J.M.
        • Jackson T.
        • Hyde E.
        • et al.
        Optimized left ventricular endocardial stimulation is superior to optimized epicardial stimulation in ischemic patients with poor response to cardiac resynchronization therapy: a combined magnetic resonance imaging, Electroanatomic Contact mapping, and Hemodynamic study to target endocardial lead placement.
        JACC Clin Electrophysiol. 2016; 2 (2405-500X (Print)): 799-809
        • Gamble J.H.P.
        • Herring N.
        • Ginks M.
        • et al.
        Endocardial left ventricular pacing for cardiac resynchronization: systematic review and meta-analysis.
        Europace. 2018; 20 (1532-2092 (Electronic)): 73-81
        • Upadhyay G.A.
        • Vijayaraman P.
        • Nayak H.M.
        • et al.
        His Corrective pacing or biventricular pacing for cardiac resynchronization in heart failure.
        J Am Coll Cardiol. 2019; 74 (1558-3597 (Electronic)): 157-159
        • Huang W.
        • Su L.
        • Wu S.
        • et al.
        A novel pacing Strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block.
        Can J Cardiol. 2017; 33 (ISSN 0828-282X. Disponível em:): 1736, e3https://doi.org/10.1016/j.cjca.2017.09.013>. Acesso em: 2021/09/02
        • Wu S.
        • Su L.
        • Vijayaraman P.
        • et al.
        Left bundle branch pacing for cardiac resynchronization therapy: Nonrandomized on-treatment comparison with His bundle pacing and biventricular pacing.
        Can J Cardiol. 2021; 37 (1916-7075 (Electronic)): 319-328
        • Liu J.
        • Sun F.
        • Wang Z.
        • et al.
        Left bundle branch area pacing vs. Biventricular pacing for cardiac resynchronization therapy: a meta-analysis.
        Front Cardiovasc Med. 2021; 8 (Available at:): 408
        • Ravi V.
        • Hanifin J.L.
        • Larsen T.
        • et al.
        The Pros and Cons of left bundle branch pacing: a single center experience.
        Circ Arrhythm Electrophysiol. 2020; 13 (Disponível em:): e008874https://doi.org/10.1161/CIRCEP.120.008874>. Acesso em: 2021/09/28
        • Arora V.
        • SURI P.
        Physiological pacing: a new Road to future.
        Indian J Clin Cardiol. 2021; 2 (ISSN 2632-4636. Disponível em:): 32-43https://doi.org/10.1177/2632463620978045>. Acesso em: 2021/09/28
        • Sidhu B.S.
        • Porter B.
        • Gould J.
        • et al.
        Leadless left ventricular endocardial pacing in nonresponders to conventional cardiac resynchronization therapy.
        Pacing Clin Electrophysiol. 2020; 43 (1540-8159 (Electronic)): 966-973
        • Brabham W.W.
        • Gold M.R.
        The role of AV and VV optimization for CRT.
        J Arrhythmia. 2013; 29 (ISSN 18804276): 153-161
        • Delnoy P.P.
        • Ritter P.
        • Naegele H.
        • et al.
        Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study.
        Europace. 2013; 15 (1532-2092 (Electronic)): 1174-1181
        • Brignole M.
        • Auricchio A.
        • Baron-Esquivias G.
        • et al.
        2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
        Europace. 2013; 15 (ISSN 1532-2092 (Electronic) 1099-5129 (Linking). Disponível em: Available at:): 1070-1118
        • Ellenbogen K.A.
        • Gold M.R.
        • Meyer T.E.
        • et al.
        Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
        Circulation. 2010; 122 (ISSN 1524-4539 (Electronic) 0009-7322 (Linking). Disponível em: Available at:): 2660-2668
        • Luceri R.M.
        • Brownstein S.L.
        • Vardeman L.
        • et al.
        PR interval behavior during exercise: implications for physiological pacemakers.
        Pacing Clin Electrophysiol. 1990; 13 (ISSN 0147-8389 (Print) 0147-8389 (Linking). Disponível em: Available at:): 1719-1723
        • Shanmugam N.
        • Prada-Delgado O.
        • Campos A.G.
        • et al.
        Rate-adaptive AV delay and exercise performance following cardiac resynchronization therapy.
        Heart Rhythm. 2012; 9 (ISSN 1556-3871 (Electronic) 1547-5271 (Linking). Disponível em: Available at:): 1815-1821
        • Ritter P.
        • Delnoy P.P.
        • Padeletti L.
        • et al.
        A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
        Europace. 2012; 14 (ISSN 1099-5129. Disponível em:): 1324-1333https://doi.org/10.1093/europace/eus059 >. Acesso em: 9/28/2021
        • Brugada J.
        • Delnoy P.P.
        • Brachmann J.
        • et al.
        Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial.
        Eur Heart J. 2017; 38 (ISSN 0195-668X. Disponível em:): 730-738https://doi.org/10.1093/eurheartj/ehw526 >. Acesso em: 9/28/2021
        • Burri H.
        • Prinzen F.W.
        • Gasparini M.
        • et al.
        Left univentricular pacing for cardiac resynchronization therapy.
        Europace. 2017; 19 (ISSN 1532-2092 (Electronic) 1099-5129 (Linking). Disponível em: Available at:): 912-919
        • Vatasescu R.
        • Berruezo A.
        • Mont L.
        • et al.
        Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping.
        Europace. 2009; 11 (ISSN 1532-2092 1099-5129. Disponível em: Available at:) (>.Disponível em): 1675-1682
        • Strik M.
        • van Middendorp L.B.
        • Houthuizen P.
        • et al.
        Interplay of electrical wavefronts as Determinant of the response to cardiac resynchronization therapy in dyssynchronous canine hearts.
        Circ Arrhythm Electrophysiol. 2013; 6 (Disponível em:): 924-931https://doi.org/10.1161/CIRCEP.113.000753>. Acesso em: 2021/09/03
        • Arbelo E.
        • Tolosana J.M.
        • Trucco E.
        • et al.
        Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.
        J Cardiovasc Electrophysiol. 2014; 25 (1540-8167 (Electronic)): 283-292
        • Birnie D.
        • Lemke B.
        • Aonuma K.
        • et al.
        Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
        Heart Rhythm. 2013; 10 (ISSN 1547-5271. Disponível em: Available at:) (>.Disponível em): 1368-1374
        • Filippatos G.
        • Birnie D.
        • Gold M.R.
        • et al.
        Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.
        Eur J Heart Fail. 2017; 19 (1879-0844 (Electronic)): 950-957
        • Pappone C.
        • Ćalović Z.
        • Vicedomini G.
        • et al.
        Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study.
        Heart Rhythm. 2015; 12 (1556-3871 (Electronic)): 1250-1258
        • Behar J.M.
        • Bostock J.
        • Li A.P.Z.
        • et al.
        Cardiac resynchronization therapy delivered via a Multipolar left ventricular lead is associated with reduced mortality and Elimination of phrenic nerve stimulation: long-term follow-up from a Multicenter registry.
        J Cardiovasc Electrophysiol. 2015; 26 (1540-8167 (Electronic)): 540-546
        • Rinaldi C.A.
        • Burri H.
        • Thibault B.
        • et al.
        A review of multisite pacing to achieve cardiac resynchronization therapy.
        Europace. 2015; 17 (ISSN 1099-5129. Disponível em:): 7-17https://doi.org/10.1093/europace/euu197 >. Acesso em: 9/3/2021
        • Zanon F.
        • Marcantoni L.
        • Baracca E.
        • et al.
        Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
        Heart Rhythm. 2016; 13 (1556-3871 (Electronic)): 1644-1651
        • Forleo G.B.
        • Santini L.
        • Giammaria M.
        • et al.
        Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP).
        Europace. 2017; 19 (1532-2092 (Electronic)): 1170-1177
        • Barold S.S.
        • Herweg B.
        Cardiac resynchronization in patients with atrial fibrillation.
        J Atr Fibrillation. 2015; 8 (ISSN 1941-6911. Disponível em: Available at:) (>.Disponível em): 1383
        • Koplan B.A.
        • Kaplan A.J.
        • Weiner S.
        • et al.
        Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?.
        J Am Coll Cardiol. 2009; 53 (1558-3597 (Electronic)): 355-360
        • Lubitz S.A.
        • SINGH J.P.
        Biventricular pacing: more is better!.
        Eur Heart J. 2015; 36 (ISSN 0195-668X. Disponível em:): 407-409https://doi.org/10.1093/eurheartj/ehu347>. Acesso em: 9/2/2021
        • Hayes D.L.
        • Boehmer J.P.
        • Day J.D.
        • et al.
        Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.
        Heart Rhythm. 2011; 8 (ISSN 1547-5271. Disponível em:): 1469-1475https://doi.org/10.1016/j.hrthm.2011.04.015 >. Acesso em: 2021/09/07
        • Ousdigian K.T.
        • Borek P.P.
        • Koehler J.L.
        • et al.
        The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
        Circ Arrhythm Electrophysiol. 2014 Jun; 7: 370-376
        • Kamath G.S.
        • Cotiga D.
        • Koneru J.N.
        • et al.
        The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.
        J Am Coll Cardiol. 2009; 53 (ISSN 0735-1097. Disponível em: Available at:): 1050-1055
        • Gasparini M.
        • Galimberti P.
        • Ceriotti C.
        The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
        Curr Opin Cardiol. 2013; 28 (ISSN 0268-4705. Disponível em: Available at:): 50
        • Gasparini M.
        • Leclercq C.
        • Lunati M.
        • et al.
        Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (cardiac resynchronization therapy in atrial fibrillation patients multinational registry).
        JACC Heart Fail. 2013; 1 (ISSN 2213-1779. Disponível em: Available at:): 500-507
        • Lakkireddy D.
        • Di Biase L.
        • Ryschon K.
        • et al.
        Radiofrequency ablation of Premature ventricular ectopy improves the Efficacy of cardiac resynchronization therapy in nonresponders.
        J Am Coll Cardiol. 2012; 60 (ISSN 0735-1097. Disponível em: Available at:): 1531-1539
        • Neubauer S.
        The failing heart--an engine out of fuel.
        N Engl J Med. 2007; 356 (Available at:): 1140-1151
        • Stanley W.C.
        • RECCHIA F.A.
        • LOPASCHUK G.D.
        Myocardial substrate metabolism in the normal and failing heart.
        Physiol Rev. 2005; 85 (ISSN 0031-9333 (Print) 0031-9333 (Linking). Disponível em: Available at:): 1093-1129
        • Zanco P.
        • Desideri A.
        • Mobilia G.
        • et al.
        Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses.
        J Nucl Med. 2000; 41 (ISSN 0161-5505 (Print) 0161-5505 (Linking). Disponível em: Available at:): 973-977
        • Degtiarova G.
        • Claus P.
        • Duchenne J.
        • et al.
        Low septal to lateral wall (18)F-FDG ratio is highly associated with mechanical dyssynchrony in non-ischemic CRT candidates.
        EJNMMI Res. 2019; 9: 105
        • Nowak B.
        • Sinha A.M.
        • Schaefer W.M.
        • et al.
        Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block.
        J Am Coll Cardiol. 2003; 41 (ISSN 07351097): 1523-1528
        • Agnetti G.
        • Kaludercic N.
        • Kane L.A.
        • et al.
        Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts.
        Circ Cardiovasc Genet. 2010; 3 (Available at:): 78-87
        • UKKONEN H.
        • et al.
        Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism.
        Circulation. 2003; 107: 28-31
        • Nelson G.S.
        • Berger R.D.
        • Fetics B.J.
        • et al.
        Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block.
        Circulation. 2000; 102 (ISSN 1524-4539 (Electronic) 0009-7322 (Linking). Disponível em: Available at:): 3053-3059
        • Obrzut S.
        • Tiongson J.
        • Jamshidi N.
        • et al.
        Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
        J Cardiovasc Transl Res. 2010; 3 (ISSN 1937-5395 (Electronic) 1937-5387 (Linking). Disponível em: Available at:): 643-651
        • Ayyadurai P.
        • Alkhawam H.
        • Saad M.
        • et al.
        An update on the CardioMEMS pulmonary artery pressure sensor.
        Ther Adv Cardiovasc Dis. 2019; 13 (ISSN 1753-9455 1753-9447. Disponível em: Available at:) (1753944719826826-1753944719826826)
        • Abraham W.T.
        • Adamson P.B.
        • Bourge R.C.
        • et al.
        Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
        Lancet. 2011; 377 (ISSN 0140-6736. Disponível em:): 658-666https://doi.org/10.1016/S0140-6736(11)60101-3 >. Acesso em: 2021/09/07
        • Angermann C.E.
        • Assmus B.
        • Anker S.D.
        • et al.
        Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
        Eur J Heart Fail. 2020; 22 (ISSN 1388-9842. Disponível em:): 1891-1901https://doi.org/10.1002/ejhf.1943 >. Acesso em: 2021/09/07
        • Borggrefe M.
        • MANN D.L.
        Cardiac contractility modulation in 2018.
        Circulation. 2018; 138 (Disponível em:): 2738-2740https://doi.org/10.1161/CIRCULATIONAHA.118.036460>. Acesso em: 2021/09/07
        • Giallauria F.
        • Vigorito C.
        • Piepoli M.F.
        • et al.
        Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
        Int J Cardiol. 2014; 175 (ISSN 0167-5273. Disponível em:): 352-357https://doi.org/10.1016/j.ijcard.2014.06.005 >. Acesso em: 2021/09/07
        • Yu C.M.
        • Chan J.Y.
        • Zhang Q.
        • et al.
        Impact of cardiac contractility modulation on left ventricular Global and Regional function and remodeling.
        JACC Cardiovasc Imaging. 2009; 2 (ISSN 1936-878X. Disponível em: Available at:): 1341-1349
        • Anker S.D.
        • Borggrefe M.
        • Neuser H.
        • et al.
        Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
        Eur J Heart Fail. 2019; 21 (ISSN 1388-9842. Disponível em:): 1103-1113https://doi.org/10.1002/ejhf.1374 >. Acesso em: 2021/09/07
        • Kloppe A.
        • Lawo T.
        • Mijic D.
        • et al.
        Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration.
        Int J Cardiol. 2016; 209 (ISSN 0167-5273. Disponível em:): 291-295https://doi.org/10.1016/j.ijcard.2016.02.001 >. Acesso em: 2021/09/07
        • Tint D.
        • FLOREA R.
        • MICU S.
        New Generation cardiac contractility modulation device-Filling the Gap in heart failure treatment.
        J Clin Med. 2019; 8 (ISSN 2077-0383. Disponível em: Available at:) (>.Disponível em): 588
        • Butter C.
        • Meyhöfer J.
        • Seifert M.
        • et al.
        First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies.
        Eur J Heart Fail. 2007; 9 (ISSN 1388-9842. Disponível em:): 955-958https://doi.org/10.1016/j.ejheart.2007.05.012 >. Acesso em: 2021/09/07
        • Abraham W.T.
        • Zile M.R.
        • Weaver F.A.
        • et al.
        Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction.
        JACC Heart Fail. 2015; 3 (ISSN 2213-1779. Disponível em: Available at:): 487-496
        • Zile M.R.
        • Lindenfeld J.
        • Weaver F.A.
        • et al.
        Baroreflex activation therapy in patients with heart failure with reduced ejection fraction.
        J Am Coll Cardiol. 2020; 76 (ISSN 0735-1097. Disponível em: Available at:): 1-13
        • Zannad F.
        • De Ferrari G.M.
        • Tuinenburg A.E.
        • et al.
        Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial.
        Eur Heart J. 2015; 36 (ISSN 0195-668X. Disponível em: Available at:): 425-433https://doi.org/10.1093/eurheartj/ehu345 >. Acesso em: 9/28/2021
        • Gold M.R.
        • Van Veldhuisen D.J.
        • Hauptman P.J.
        • et al.
        Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial.
        J Am Coll Cardiol. 2016; 68 (ISSN 0735-1097. Disponível em: Available at:): 149-158
        • Premchand R.K.
        • Sharma K.
        • Mittal S.
        • et al.
        Autonomic Regulation therapy via left or right Cervical Vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
        J Card Fail. 2014; 20 (ISSN 1071-9164. Disponível em:): 808-816https://doi.org/10.1016/j.cardfail.2014.08.009>. Acesso em: 2021/09/28
        • Herring N.
        • Kalla M.
        • Paterson D.J.
        The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies.
        Nat Rev Cardiol. 2019; 16 (ISSN 1759-5010. Disponível em:): 707-726https://doi.org/10.1038/s41569-019-0221-2
        • Zipes D.P.
        • Neuzil P.
        • Theres H.
        • et al.
        Determining the Feasibility of spinal cord neuromodulation for the treatment of chronic systolic heart failure: the DEFEAT-HF study.
        JACC Heart Fail. 2016; 4 (ISSN 2213-1779. Disponível em: Available at:): 129-136
        • Cavaco D.M.
        Response to cardiac resynchronization therapy: dichotomous or continuous variable?.
        Rev Port Cardiol. 2017; 36 (2174-2030 (Electronic)): 893-894
        • Rickard J.
        • Michtalik H.
        • Sharma R.
        • et al.
        Predictors of response to cardiac resynchronization therapy: a systematic review.
        Int J Cardiol. 2016; 225 (1874-1754 (Electronic)): 345-352
        • Curtis A.B.
        • POOLE J.E.
        The right response to Nonresponse to cardiac resynchronization therapy.
        J Am Coll Cardiol. 2019; 74 (1558-3597 (Electronic)): 2604-2606
        • Sidhu B.S.
        • Rua T.
        • Gould J.
        • et al.
        Economic evaluation of a dedicated cardiac resynchronisation therapy preassessment clinic.
        Open Heart. 2020; 7 (Disponível em: Available at:): e001249
        • Gorodeski E.Z.
        • Magnelli-Reyes C.
        • Moennich L.A.
        • et al.
        Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: a novel model of care.
        PloS one. 2019; 14 (ISSN 1932-6203. Disponível em: Available at:) (>.Disponível em): e0222610